{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "离靶效应",
            "expectation": "量化离靶效应的风险，并探讨其可能对疗效的影响",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "离靶效应",
            "expectation": "量化离靶效应的风险，并探讨其可能对疗效的影响",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thrombopoietin_receptor_agonists",
          "type": "Drug",
          "label": "Thrombopoietin receptor agonists",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anticoagulants",
          "type": "Drug",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_belatacept",
          "type": "Drug",
          "label": "Belatacept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Target_C5",
          "type": "Target",
          "label": "C5 Complement Protein",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Pathway_complement_system",
          "type": "Pathway",
          "label": "Complement System",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Disease_aHUS",
          "type": "Disease",
          "label": "Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_renal_failure",
          "type": "Phenotype",
          "label": "Renal Failure",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_thrombocytopenia",
          "type": "Phenotype",
          "label": "Thrombocytopenia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_thrombopoietin_receptor_agonists",
          "type": "Drug",
          "label": "Thrombopoietin receptor agonists",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_anticoagulants",
          "type": "Drug",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_belatacept",
          "type": "Drug",
          "label": "Belatacept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_phenotype",
          "type": "Phenotype",
          "label": "Adverse Phenotypes of Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_eculizumab",
          "type": "Target",
          "label": "Off-target effects of Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ravulizumab",
          "type": "Target",
          "label": "Off-target effects of Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_corticosteroids",
          "type": "Target",
          "label": "Off-target effects of Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "Risk associated pathways",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_eculizumab",
          "target": "Target_C5",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "针对C5补体蛋白的靶向作用"
        },
        {
          "source": "drug_ravulizumab",
          "target": "Target_C5",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "针对C5补体蛋白的靶向作用"
        },
        {
          "source": "Target_C5",
          "target": "Pathway_complement_system",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "补体系统的关键成分"
        },
        {
          "source": "Pathway_complement_system",
          "target": "Disease_aHUS",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "补体系统异常与aHUS相关"
        },
        {
          "source": "Pathway_complement_system",
          "target": "Phenotype_renal_failure",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与肾功能衰竭的直接关联"
        },
        {
          "source": "Pathway_complement_system",
          "target": "Phenotype_thrombocytopenia",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与血小板减少症的直接关联"
        },
        {
          "source": "drug_corticosteroids",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于管理相关并发症"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于免疫抑制治疗"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "对于免疫相关疾病的治疗"
        },
        {
          "source": "drug_thrombopoietin_receptor_agonists",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "刺激血小板生成的潜在疗法"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "Disease_aHUS",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "血浆置换在aHUS治疗中的应用"
        },
        {
          "source": "drug_anticoagulants",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "防止血栓形成的处理"
        },
        {
          "source": "drug_aspirin",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "在血小板减少症的辅助使用"
        },
        {
          "source": "drug_sirolimus",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "用于控制免疫反应"
        },
        {
          "source": "drug_rituximab",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "治疗免疫性疾病"
        },
        {
          "source": "drug_belatacept",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "作为免疫抑制剂的应用"
        },
        {
          "source": "n_eculizumab",
          "target": "n_ot_eculizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能存在离靶作用导致不良反应"
        },
        {
          "source": "n_ravulizumab",
          "target": "n_ot_ravulizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能存在离靶作用导致不良反应"
        },
        {
          "source": "n_corticosteroids",
          "target": "n_ot_corticosteroids",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能存在离靶作用导致不良反应"
        },
        {
          "source": "n_ot_eculizumab",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路"
        },
        {
          "source": "n_ot_ravulizumab",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路"
        },
        {
          "source": "n_ot_corticosteroids",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路"
        },
        {
          "source": "n_rp",
          "target": "n_phenotype",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "与不良表型相关时可能加重病情"
        },
        {
          "source": "n_ph__enotype",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果存在离靶效应，则Eculizumab的疗效将受到影响"
        },
        {
          "source": "n_ph__enotype",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果存在离靶效应，则Ravulizumab的疗效将受到影响"
        },
        {
          "source": "n_ph__enotype",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果存在离靶效应，则Corticosteroids的疗效将受到影响"
        }
      ],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [
            {
              "id": "n_ot_eculizumab_risk",
              "type": "Pathway",
              "label": "Eculizumab Off-target Risk Pathway",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_ot_ravulizumab_risk",
              "type": "Pathway",
              "label": "Ravulizumab Off-target Risk Pathway",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_ot_corticosteroids_risk",
              "type": "Pathway",
              "label": "Corticosteroids Off-target Risk Pathway",
              "attrs": {
                "agent": "Skeptic"
              }
            }
          ],
          "add_edges": [
            {
              "source": "n_ot_eculizumab",
              "target": "n_ot_eculizumab_risk",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "潜在的风险通路"
            },
            {
              "source": "n_ot_ravulizumab",
              "target": "n_ot_ravulizumab_risk",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "潜在的风险通路"
            },
            {
              "source": "n_ot_corticosteroids",
              "target": "n_ot_corticosteroids_risk",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "潜在的风险通路"
            },
            {
              "source": "n_ot_eculizumab_risk",
              "target": "n_phenotype",
              "relation": "causes",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "与不良表型相关，加重病情"
            },
            {
              "source": "n_ot_ravulizumab_risk",
              "target": "n_phenotype",
              "relation": "causes",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "与不良表型相关，加重病情"
            },
            {
              "source": "n_ot_corticosteroids_risk",
              "target": "n_phenotype",
              "relation": "causes",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "与不良表型相关，加重病情"
            },
            {
              "source": "n_ph__enotype",
              "target": "H1",
              "relation": "refutes",
              "weight": 0.85,
              "agent": "Skeptic",
              "rationale": "如果存在离靶效应，则Eculizumab的疗效将受到影响"
            },
            {
              "source": "n_ph__enotype",
              "target": "H2",
              "relation": "refutes",
              "weight": 0.85,
              "agent": "Skeptic",
              "rationale": "如果存在离靶效应，则Ravulizumab的疗效将受到影响"
            },
            {
              "source": "n_ph__enotype",
              "target": "H3",
              "relation": "refutes",
              "weight": 0.85,
              "agent": "Skeptic",
              "rationale": "如果存在离靶效应，则Corticosteroids的疗效将受到影响"
            }
          ],
          "merge": [
            {
              "keep": "n_rp",
              "remove": "n_rp_dup",
              "rationale": "同义风险通路合并"
            }
          ],
          "conflict_hotspots": [
            {
              "topic": "Off-target Effects",
              "pro_nodes": [
                "n_eculizumab",
                "n_ravulizumab",
                "n_corticosteroids"
              ],
              "con_nodes": [
                "n_ot_eculizumab_risk",
                "n_ot_ravulizumab_risk",
                "n_ot_corticosteroids_risk"
              ],
              "note": "药物疗效的潜在离靶效应"
            }
          ]
        },
        "notes": "已完成离靶效应的安全性压力测试并更新图"
      }
    ],
    "unexecuted_actions": [],
    "residual_conflicts": [
      "潜在的离靶作用与治疗效果的冲突"
    ]
  }
}